93 related articles for article (PubMed ID: 3612685)
21. Anti-tumor efficacy of new 7α-substituted androstanes as aromatase inhibitors in hormone-sensitive and resistant breast cancer cells.
Amaral C; Varela CL; Maurício J; Sobral AF; Costa SC; Roleira FMF; Tavares-da-Silva EJ; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2017 Jul; 171():218-228. PubMed ID: 28396197
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biochemical studies of 16- or 19-substituted androst-4-enes as aromatase inhibitors.
Numazawa M; Mutsumi A; Hoshi K; Oshibe M; Ishikawa E; Kigawa H
J Med Chem; 1991 Aug; 34(8):2496-504. PubMed ID: 1875347
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and pharmacological properties of derivatives of isoxazolo [5,4-d]-6,7-dihydropyrimidines.
Machoń Z; Ryng S
Pol J Pharmacol Pharm; 1988; 40(2):209-16. PubMed ID: 3237570
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
25. Interactions of thiol-containing androgens with human placental aromatase.
Bednarski PJ; Nelson SD
J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733
[TBL] [Abstract][Full Text] [Related]
26. Aromatase inactivation by 2-substituted derivatives of the suicide substrate androsta-1,4-diene-3,17-dione.
Takahashi M; Handa W; Umeta H; Ishikawa S; Yamashita K; Numazawa M
J Steroid Biochem Mol Biol; 2009 Sep; 116(3-5):191-9. PubMed ID: 19520161
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human estrogen synthetase (aromatase) by flavones.
Kellis JT; Vickery LE
Science; 1984 Sep; 225(4666):1032-4. PubMed ID: 6474163
[TBL] [Abstract][Full Text] [Related]
28. Ovarian P450 aromatase activity in the catfish Heteropneustes fossilis: seasonal changes and effects of catecholestrogens.
Chourasia TK; Joy KP
Gen Comp Endocrinol; 2008 May; 156(3):537-43. PubMed ID: 18395205
[TBL] [Abstract][Full Text] [Related]
29. Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease.
Browne LJ; Gude C; Rodriguez H; Steele RE; Bhatnager A
J Med Chem; 1991 Feb; 34(2):725-36. PubMed ID: 1825337
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and aromatase-inhibitory activity of imidazolyl-1,3,5-triazine derivatives.
Matsuno T; Kato M; Tsuchida Y; Takahashi M; Yaguchi S; Terada S
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):291-6. PubMed ID: 9118443
[TBL] [Abstract][Full Text] [Related]
31. In vitro inhibition of aromatase by the enantiomers of aminoglutethimide and analogs.
Ogbunude PO; Aboul-Enein HY
Chirality; 1994; 6(8):623-6. PubMed ID: 7857773
[TBL] [Abstract][Full Text] [Related]
32. 2,4-Diamino-5-benzylpyrimidines and analogues as antibacterial agents. 10. 2,4-Diamino-5-(6-quinolylmethyl)- and -[(tetrahydro-6-quinolyl)methyl]pyrimidine derivatives. Further specificity studies.
Rauckman BS; Tidwell MY; Johnson JV; Roth B
J Med Chem; 1989 Aug; 32(8):1927-35. PubMed ID: 2502632
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biochemical evaluation of inhibitors of estrogen biosynthesis.
Brueggemeier RW; Floyd EE; Counsell RE
J Med Chem; 1978 Oct; 21(10):1007-11. PubMed ID: 722711
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of 4-(substituted thio)-4-androstene-3,17-dione derivatives as potential aromatase inhibitors.
Abul-Hajj YJ
J Med Chem; 1986 Apr; 29(4):582-4. PubMed ID: 3959033
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships of 2-, 4-, or 6-substituted estrogens as aromatase inhibitors.
Numazawa M; Ando M; Watari Y; Tominaga T; Hayata Y; Yoshimura A
J Steroid Biochem Mol Biol; 2005 Jun; 96(1):51-8. PubMed ID: 16039845
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine kinase inhibitors. 13. Structure-activity relationships for soluble 7-substituted 4-[(3-bromophenyl)amino]pyrido[4,3-d]pyrimidines designed as inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
Thompson AM; Murray DK; Elliott WL; Fry DW; Nelson JA; Showalter HD; Roberts BJ; Vincent PW; Denny WA
J Med Chem; 1997 Nov; 40(24):3915-25. PubMed ID: 9397172
[TBL] [Abstract][Full Text] [Related]
37. Biological evaluation of 5-substituted pyrimidine derivatives as inhibitors of brassinosteroid biosynthesis.
Wang JM; Asami T; Yoshida S; Murofushi N
Biosci Biotechnol Biochem; 2001 Apr; 65(4):817-22. PubMed ID: 11388458
[TBL] [Abstract][Full Text] [Related]
38. A microsomal based method to detect aromatase activity in different brain regions of the rat using ultra performance liquid chromatography-mass spectrometry.
Li J; Oberly PJ; Poloyac SM; Gibbs RB
J Steroid Biochem Mol Biol; 2016 Oct; 163():113-20. PubMed ID: 27113434
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 1. Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids.
Beck G; Kesseler K; Baader E; Bartmann W; Bergmann A; Granzer E; Jendralla H; von Kerekjarto B; Krause R; Paulus E
J Med Chem; 1990 Jan; 33(1):52-60. PubMed ID: 2296036
[TBL] [Abstract][Full Text] [Related]
40. Novel sulfonanilide analogues suppress aromatase expression and activity in breast cancer cells independent of COX-2 inhibition.
Su B; Diaz-Cruz ES; Landini S; Brueggemeier RW
J Med Chem; 2006 Feb; 49(4):1413-9. PubMed ID: 16480277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
